News

Read the latest updates about BioMarin and learn more about our science, our people and the communities we support.

Lynsey Chediak

From Patient to Policy Advocate: A Journey Rooted in Urgency and Hope

October 22, 2025

2025-26 class of BioMarin RARE Scholars award recipients

Community

From Healthcare to Computer Science and Law, RARE Scholars Draw on Lived Experiences to Pursue Their Dreams

October 14, 2025

Terri Klein National MPS Society

Community

Terri Klein on How Her Personal Experience Has Shaped the National MPS Society’s Groundbreaking Programs for Families

October 8, 2025

Stories

All Stories

Christina Pao Signature Science

Christina Pao on Charting a New Course for Children with Hypochondroplasia

October 30, 2025

Lynsey Chediak

From Patient to Policy Advocate: A Journey Rooted in Urgency and Hope

October 22, 2025

2025-26 class of BioMarin RARE Scholars award recipients

Community

From Healthcare to Computer Science and Law, RARE Scholars Draw on Lived Experiences to Pursue Their Dreams

October 14, 2025

Terri Klein National MPS Society

Community

Terri Klein on How Her Personal Experience Has Shaped the National MPS Society’s Groundbreaking Programs for Families

October 8, 2025

Javier Femenia Helps Turn Promising Molecules into Breakthrough Medicines

September 30, 2025

DNA of BioMarin Letticia Atkins

People and Culture

Leading with Heart: Letticia Atkins Brings the Spirit of Family to Her Work at BioMarin

September 22, 2025

Press Releases

All Press Releases

FDA Accepts BioMarin’s PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria

October 29, 2025

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

October 27, 2025

BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

October 22, 2025

BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting

September 8, 2025

BioMarin Announces Positive Pivotal Phase 3 Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria at 15th International Congress of Inborn Errors of Metabolism

September 6, 2025